UCB and Biogen (BIIB) presented detailed results from the Phase 3 PHOENYCS GO study evaluating dapirolizumab pegol, or DZP, a novel Fc-free anti-CD40L drug candidate, demonstrating significant ...

Diwas Budhathoki, the dedicated Pokemon aficionado, is your guide into the Pokemon franchise. His eSports writing journey began years ago, and he's been sharing his passion through GameRant since ...

(RTTNews) - UCB and Biogen Inc. (BIIB) presented detailed results from the Phase 3 PHOENYCS GO study evaluating dapirolizumab pegol, a Fc-free anti-CD40L drug candidate, showing significant clinical ...

Three days of electric Pokémon. October is a busy month for Pokémon Go fans. Already, the Daily PokeCoin Bounty Part 2 ticket has kicked off, while a Mega Mawile Raid Day and Magnetic Study event are ...

UCB and Biogen have announced positive Phase III clinical trial results for PHOENYCS GO study, evaluating dapirolizumab pegol, a new treatment for moderate-to-severe systemic lupus erythematosus (SLE) ...

The Magnetic Study event runs from Tuesday, October 15th, at 12:00AM to Thursday, October 17th, 2024, at 11:59PM local time.

Dapirolizumab pegol demonstrated significant efficacy in reducing fatigue and disease activity in systemic lupus erythematosus patients during the PHOENYCS GO study. Dapirolizumab pegol (DZP), a novel ...